AJANTPHARM - Ajanta Pharma

Ajanta Pharma

AJANTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Mannalal B Agrawal · MD: Yogesh M Agrawal · Listing date: June 1, 2000 · Employees: 7035 · Mumbai · http://www.ajantapharma.com

Stock Price vs Company Growth

0.1%

4.8%

3.5%

9.1%

10.9%

59.4%

33.4%

10y

19.4%

all

41.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 2,401 0.1%

2,117

2,532

Company Overview

Sales

4,209 Cr

Growth: 10.5%

Profit after Tax

816 Cr

Growth: 10.9%

Mid Cap

29,980 Cr

P/E: 37.1x

Industry P/E: 37.3x

Fundamentals

Sales (Cr)	₹ 4,209
Growth	10.5%
EBITDA	27.4%
P/S	7.1x
Dividend	1.7%
P/E	37.1x
Book Value	₹ 286
PEG Ratio	3.5x
ROE	21.8%
P/B	8.4x

Shareholding Pattern

Institutions

Uti Flexi Cap Fund

3.46 %

Mirae Asset Emerging Bluechip Fund

3.41 %

Sbi Magnum Global Fund

1.28 %

Llp

0.08 %

Iepf

0.06 %

Promoters

Rajesh M Agrawal, Trustee Rajesh Agrawal Trust

14.48 %

Yogesh M Agrawal, Trustee Yogesh Agrawal Trust

14.48 %

Ravi P Agrawal, Trustee Ravi Agrawal Trust

14.37 %

Aayush M Agrawal, Trustee Aayush Agrawal Trust

14.36 %

Gabs Investments Pvt Ltd

9.7 %

Others

Increase Decrease No change

Company Profile Detailed

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company’s branded generic business where it is present across Asia and Africa.

Belongs to (20 Indices) view more

Investors (132)

sbi.magn...

icici.pr...

india.ac...

Followers (27)

nitin2

keerthi

deepak